Launch of a new mass-production project in the contract manufacturing business
First written in FY2023-Q1. 2 of 11 entries say "Advanced", first in FY2025-H1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Revenue and earnings decline due to weaker demand for new mass-production projectsAnnual report
「The contract manufacturing business reported lower revenue and profit year on year because demand for circuit boards for occlusal-force measurement equipment for dental treatment decreased from the same period of the previous year. For the current consolidated fiscal year, revenue was ¥110 million, down 44.3% year on year, and segment profit was ¥37 million, compared with segment profit of ¥50 million in the previous year.」
Demand for the circuit boards for dental treatment launched as a new mass-production project to offset the decline in existing products decreased over the full fiscal year, contributing to lower revenue and profit in the contract manufacturing business. - FY2026-H1Declining demand for new mass-production projectsAnnual report
「In the contract manufacturing business, revenue and profit declined year on year because demand for circuit boards for bite-force measurement equipment for dental practices decreased from the same period of the previous year. Revenue for the current interim consolidated accounting period was ¥31 million (down 82.0% year on year), and segment profit was ¥5 million (compared with segment profit of ¥42 million in the previous interim consolidated accounting period).」
Demand for the circuit boards for dental-treatment use developed as a new mass-production project to offset the decline in existing products decreased during the interim period, contributing to lower revenue and profit in the contract manufacturing business. - FY2025AdvancedAnnual report
「In the contract manufacturing business, sales of circuit boards for bite-force measurement equipment for dental practices, which the company has been developing since the previous fiscal year, progressed smoothly. As a result, revenue for the current consolidated fiscal year was ¥199 million (up 251.1% year on year), and segment profit was ¥50 million (up 402.9% year on year).」
The new mass-production project intended to offset the decline in existing products expanded sales over the full fiscal year and contributed to higher revenue and profit in the contract manufacturing business. - FY2025-H1AdvancedAnnual report
「In the contract manufacturing business, sales of circuit boards for bite-force measurement equipment for dental practices, which the company has been developing since the previous fiscal year, progressed smoothly. As a result, revenue for the current interim consolidated accounting period was ¥175 million (year-on-year change: —%), and segment profit was ¥42 million (compared with a segment loss of ¥2 million in the previous interim consolidated accounting period).」
The new mass-production project launched in the third quarter of the previous fiscal year progressed steadily during the interim period and contributed to the contract manufacturing business turning profitable. - FY2024Contribution from the new mass-production project confirmedAnnual report
「As a new mass-production project, sales of circuit boards for occlusal-force measurement equipment for the medical industry began in the third quarter of the previous fiscal year, contributing to performance.」
The company disclosed the contribution to current-year performance from the new mass-production project for the medical industry whose sales began in the third quarter of the previous fiscal year. - FY2024-Q3The plan to recognize revenue from the new mass-production project in the fourth quarter remained unchanged.Annual report
「In the contract manufacturing business, as orders for banknote validator sensor modules and communications amusement equipment declined, sales of circuit boards for bite-force measurement equipment for the medical industry began in the previous third quarter as a new mass-production project. Revenue is scheduled to be recorded in the fourth quarter of the current consolidated fiscal year, so revenue remained sluggish, as in the second quarter.」
Following the start of sales of the new mass-production project, the company continues to plan to recognize revenue in the fourth quarter. Through the cumulative third-quarter period, revenue recognition had not yet begun, and the project's contribution to offsetting the decline in existing products remained limited. - FY2024-Q2The plan to recognize revenue from the new mass-production project in the second half remained unchanged.Annual report
「In the contract manufacturing business, orders for banknote authentication sensor modules and communications amusement equipment declined, while sales of circuit boards for bite-force measurement equipment for the medical industry began in the third quarter of the previous fiscal year as a new mass-production project. Revenue recognition for the current fiscal year was scheduled for the second half, so revenue remained sluggish, as in the first quarter.」
For the circuit boards for occlusal-force measurement equipment for the medical industry whose sales began in the third quarter of the previous fiscal year, the company maintained its plan to recognize revenue in the second half of the current consolidated fiscal year, but revenue during the cumulative second-quarter period remained weak. - FY2024-Q1No shipments of the new mass-production project were made during the quarter.Annual report
「As a new mass-production project, sales of circuit boards for occlusal-force measurement equipment for the medical industry began in the third quarter of the previous fiscal year, and revenue is expected to be recognized during the current consolidated fiscal year, but there were no shipments in the first quarter.」
For the new mass-production project whose sales began in the third quarter of the previous fiscal year, the company maintained its plan to recognize revenue during the current consolidated fiscal year, but recorded no shipments in the first quarter. - FY2023-Q3AchievedAnnual report
「In the contract manufacturing business, sales of circuit boards for occlusal-force measurement equipment for the medical industry, as a new mass-production project, began in the third quarter of the current consolidated fiscal year.」
For the new mass-production project prepared as a means of offsetting the decline in existing products, sales of circuit boards for occlusal-force measurement equipment for the medical industry began in the third quarter, against the target of starting sales during the current fiscal year. - FY2023-Q2RestatedAnnual report
「In the contract manufacturing business, preparations are currently under way to launch new mass-production projects to offset the decline in existing products, with sales targeted to begin during the current fiscal year.」
Preparations continue for new mass-production projects intended to offset the decline in existing products, with sales still targeted to begin during the current fiscal year. No new achievement, such as the start of sales, has been disclosed. - FY2023-Q1First statedAnnual report
「In the contract manufacturing business, preparations are currently under way to launch new mass-production projects to offset the decline in existing products, with sales targeted to begin during the current fiscal year.」
The company disclosed for the first time its preparations to launch new mass-production projects and its target of beginning sales during the current fiscal year as a means of offsetting declining demand for existing products.